ProShares UltraShort Nasdaq Biotechnology -2x Shares 

$8.78
8
-$0.21-2.39% Monday 21:00

Statistics

Day High
9.07
Day Low
8.76
52W High
25.87
52W Low
8.37
Volume
33,424
Avg. Volume
19,227
Mkt Cap
0
P/E Ratio
-
Dividend Yield
5.67%
Dividend
0.5

Upcoming

Dividends

5.67%Dividend Yield
Dec 25
$0.1
Sep 25
$0.15
Jul 25
$0.11
Apr 25
$0.13
Dec 24
$0.21
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
16.33%
1Y Growth
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BIS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Direxion Daily S&P Biotech Bear 3X Shares
LABD
Mkt Cap0
Direxion Daily S&P Biotech Bear 3X Shares, offers 3x inverse exposure to an index of US biotechnology stocks, competing directly with BIS's inverse biotech focus.
ProShares UltraShort MSCI Brazil Capped -2x Shares
BZQ
Mkt Cap0
ProShares UltraShort MSCI Brazil Capped, offers -2x exposure to Brazilian stocks, including biotech, competing in the inverse ETF space.
ProShares UltraShort QQQ -2x Shares
QID
Mkt Cap0
ProShares UltraShort QQQ, offers -2x exposure to the NASDAQ-100 Index, competing by targeting a similar index but broader than just biotech.
ProShares UltraPro Short QQQ -3x Shares
SQQQ
Mkt Cap0
ProShares UltraPro Short QQQ, offers -3x exposure to the NASDAQ-100, directly competing in the inverse market with a focus on tech, including biotech.
Zenas Biopharma
ZBIO
Mkt Cap1.41B
ProShares UltraPro Short NASDAQ Biotechnology, offers -3x exposure to the NASDAQ Biotechnology Index, a direct competitor with a higher leverage point.
Direxion Daily S&P Biotech Bull 3X Shares
LABU
Mkt Cap0
Direxion Daily S&P Biotech Bull 3X Shares, the bullish counterpart to LABD, competes by offering the opposite investment strategy in the same sector.
VanEck Biotech
BBH
Mkt Cap0
VanEck Vectors Biotech ETF, offers exposure to biotech stocks, competing as a non-leveraged alternative in the biotech investment space.
iShares Biotechnology
IBB
Mkt Cap0
iShares Biotechnology ETF, provides exposure to a similar biotech index, competing as a more traditional, non-leveraged investment option.
State Street SPDR S&P Biotech
XBI
Mkt Cap0
SPDR S&P Biotech ETF, competes by offering exposure to the biotech sector in a non-leveraged format, appealing to a different risk profile.
ALPS Medical Breakthroughs
SBIO
Mkt Cap0
ALPS Medical Breakthroughs ETF, competes by focusing on small- to mid-cap biotechnology and medical research companies, offering a different take on the biotech sector.

About

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
Show more...
CEO
Country
US
ISIN
US74347G8380

Listings

0 Comments

Share your thoughts

FAQ

What is ProShares UltraShort Nasdaq Biotechnology -2x Shares stock price today?
The current price of BIS is $8.78 USD — it has decreased by -2.39% in the past 24 hours. Watch ProShares UltraShort Nasdaq Biotechnology -2x Shares stock price performance more closely on the chart.
What is ProShares UltraShort Nasdaq Biotechnology -2x Shares stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange ProShares UltraShort Nasdaq Biotechnology -2x Shares stocks are traded under the ticker BIS.
Is ProShares UltraShort Nasdaq Biotechnology -2x Shares stock price growing?
BIS stock has risen by +2.52% compared to the previous week, the month change is a -7.5% fall, over the last year ProShares UltraShort Nasdaq Biotechnology -2x Shares has showed a -47.7% decrease.
Does ProShares UltraShort Nasdaq Biotechnology -2x Shares pay dividends?
Yes, BIS dividends are paid quarterly. The last dividend per share was 0.1 USD. As of today, Dividend Yield (FWD)% is 5.67%.
When did ProShares UltraShort Nasdaq Biotechnology -2x Shares complete a stock split?
The last stock split for ProShares UltraShort Nasdaq Biotechnology -2x Shares was on August 18, 2020 with a ratio of 1:4.